- Home
- MRBK vs FENC Comparison
MRBK vs FENC Comparison
Compare MRBK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- FENC
- Stock Information
- Founded
- MRBK 2004
- FENC 1996
- Country
- MRBK United States
- FENC United States
- Employees
- MRBK N/A
- FENC N/A
- Industry
- MRBK Major Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MRBK Finance
- FENC Health Care
- Exchange
- MRBK Nasdaq
- FENC Nasdaq
- Market Cap
- MRBK 185.1M
- FENC 156.9M
- IPO Year
- MRBK 2017
- FENC 2001
- Fundamental
- Price
- MRBK $12.51
- FENC $5.23
- Analyst Decision
- MRBK Buy
- FENC Strong Buy
- Analyst Count
- MRBK 2
- FENC 2
- Target Price
- MRBK $16.00
- FENC $14.00
- AVG Volume (30 Days)
- MRBK 57.4K
- FENC 125.4K
- Earning Date
- MRBK 04-25-2025
- FENC 05-13-2025
- Dividend Yield
- MRBK 3.74%
- FENC N/A
- EPS Growth
- MRBK 25.00
- FENC N/A
- EPS
- MRBK 1.45
- FENC N/A
- Revenue
- MRBK $100,935,000.00
- FENC $47,538,000.00
- Revenue This Year
- MRBK $22.20
- FENC $2.68
- Revenue Next Year
- MRBK $9.93
- FENC $71.63
- P/E Ratio
- MRBK $9.21
- FENC N/A
- Revenue Growth
- MRBK 7.27
- FENC 123.69
- 52 Week Low
- MRBK $8.26
- FENC $3.96
- 52 Week High
- MRBK $17.33
- FENC $11.15
- Technical
- Relative Strength Index (RSI)
- MRBK 21.17
- FENC 33.10
- Support Level
- MRBK $14.15
- FENC $5.47
- Resistance Level
- MRBK $14.93
- FENC $6.90
- Average True Range (ATR)
- MRBK 0.46
- FENC 0.33
- MACD
- MRBK -0.08
- FENC -0.12
- Stochastic Oscillator
- MRBK 6.30
- FENC 0.00
About MRBK Meridian Corporation
Meridian Corp is a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three business segments including Bank, Wealth, and Mortgage. It generates maximum revenue from the Bank segment that consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans, resulting in the generation of net interest income, and other sources.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.